$UZX

Linkage Global Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Linkage Global Inc. (NASDAQ: UZX) said Nasdaq notified it on June 3, 2026 that its Class A ordinary shares failed the $1 minimum bid price requirement for 30 straight business days, under Nasdaq Rule 5550(a)(2). The notice has no immediate trading impact. The company has 180 days, until Nov. 30, 2026, to regain compliance, with a possible 180-day extension via reverse split if eligible.

Original reporting
Published Jun 5, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 9:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Linkage Global Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement — source image
Decision brief

The 30-second read

$UZXBearishMed
01

Why it matters

UZX now faces a defined path to regain compliance (potentially including a reverse stock split) or face delisting notice if it cannot cure deficiency or meet other continued listing standards.

02

Market read

This is a concrete listing-compliance catalyst that can drive valuation compression and higher volatility for UZX until compliance is restored or delisting risk becomes imminent.

03

What to watch

Traders should monitor whether UZX’s bid price can recover organically (liquidity/volume, financing, market-making) versus relying solely on a reverse split.

Relevance 9/10Novelty 9/10Timing: Immediately after-hours/next-session positioning around delisting overhang and cure-period expectations

Background

Nasdaq Listing Rule 5550(a)(2) requires a minimum $1 bid price; failure for 30 consecutive business days triggers a compliance notification and a cure period.

Company-level read

Ticker impact

$UZXBearishHigh confidence
Context

Nasdaq notified Linkage Global that UZX failed the $1 minimum bid price rule for 30 straight days, triggering a 180-day cure period.

Expected impact

Near-term downside bias from delisting overhang; volatility likely increases around compliance milestones and any reverse-split signaling.

Evidence & confidence

The article is a direct Nasdaq compliance notice tied to the continued listing rule and provides explicit cure timelines and possible reverse-split eligibility.

Market effects

Reinforces ongoing Nasdaq bid-price compliance pressure for micro/small-cap issuers, potentially increasing sector-wide volatility and reverse-split chatter.

Limited direct regional spillover; primarily affects US-listed small-cap sentiment despite Tokyo HQ.

Low; this is company-specific listing compliance rather than a cross-market macro shock.

Counterpoint

Because the notice has no immediate effect on trading and provides a long compliance window, the market may over-discount delisting risk.

Key entities

  • Linkage Global Inc.

    Nasdaq-listed issuer (UZX) that received the minimum bid price deficiency notice.

  • Nasdaq Listing Qualifications Department

    The Nasdaq unit that issued the notification letter based on the last 30 business days’ closing bid price.

Related articles

$UZXMedAI 9/10

Linkage Global Inc. Announces $8 Million Share Repurchase Program

Linkage Global Inc. (NASDAQ: UZX) said its management approved an $8 million share repurchase program for Class A ordinary shares. The company plans to buy shares from time to time via open-market or other permitted transactions, funded by existing cash and future cash flow. Timing and size will depend on capital needs and market conditions.

$RAPPHighAI 9/10

Why is Rapport Therapeutics stock sliding today?

Rapport Therapeutics Inc (RAPP) shares fell 17.1% to $22.84 after pricing a $365 million capital raise, including a $175 million common stock offering at a 24% discount. The company aims to use proceeds for clinical trials and operations through 2029. Insider selling and the large offering size contributed to the decline, with the stock reaching a 52-week low. The broader market was positive, indicating company-specific pressure.

$AVPTHigh

Why is Avepoint stock rallying today?

Avepoint (AVPT) stock rose 4.1% after S&P Dow Jones Indices announced it will join the S&P SmallCap 600 index on November 2, replacing LXP Industrial Trust. The move is driven by expected buying from passive funds tracking the index. AVPT reached a 52-week high of $17.16, up 94% from its low.

$VLOHigh

Trump’s Energy Secretary Says More Russian Diesel Is Coming to America

Energy Secretary Chris Wright stated that more Russian diesel could come to the U.S. under a six-month sanctions waiver, aiming to incentivize Russia to end the Ukraine war. Refiner shares like Valero (VLO), Marathon (MPC), and Phillips 66 (PSX) fell, with declines ranging from 7.03% to 9.24%. Heating oil futures also dropped 2.79%. The waiver allows 800,000 metric tons of Russian diesel exports in October and November, with potential for 3 million more tons later.